151 results on '"Nielsen, Ulrik"'
Search Results
2. Data-driven method for hydrodynamic model estimation applied to an unmanned surface vehicle
3. Identification and high-throughput genotyping of single nucleotide polymorphism markers in a non-model conifer (Abies nordmanniana (Steven) Spach)
4. Estimating waves via measured ship responses
5. Application of Real-Time Estimation Techniques for Stability Monitoring of Fishing Vessels
6. Onboard identification of stability parameters including nonlinear roll damping via phase-resolved wave estimation using measured ship responses
7. Capturing the effect of biofouling on ships by incremental machine learning
8. Wave spectrum estimation conditioned on machine learning-based output using the wave buoy analogy
9. Deriving spatial wave data from a network of buoys and ships
10. Estimating speed-through-water by Dynamic Factor Models fusing metocean and propeller data
11. Estimation of encountered wave elevation sequences based on response measurements in multi-directional seas
12. Assessment of added resistance estimates based on monitoring data from a fleet of container vessels
13. Automatic sea state estimation with online trust measure based on ship response measurements
14. Monitoring hydrodynamic vessel performance by incremental machine learning using in-service data
15. Validation and correction of auto-logged position measurements
16. Simultaneous sea state estimation and transfer function tuning using a network of dynamically positioned ships
17. Sea state identification using machine learning—A comparative study based on in-service data from a container vessel
18. Parameterised transfer functions with associated confidence bands
19. Reconstruction of incident wave profiles based on short-time ship response measurements
20. Short-time FORM analysis for extreme roll motion prediction in beam seas
21. Data-driven prediction of added-wave resistance on ships in oblique waves—A comparison between tree-based ensemble methods and artificial neural networks
22. Prediction of ships’ speed-power relationship at speed intervals below the design speed
23. Wave conditions encountered by ships—A report from a larger shipping company based on ERA5
24. Tuning of transfer functions for analysis of wave–ship interactions
25. Estimation of autocorrelation function and spectrum density of wave-induced responses using prolate spheroidal wave functions
26. Supplementary Table 4 from MM-141, an IGF-IR– and ErbB3-Directed Bispecific Antibody, Overcomes Network Adaptations That Limit Activity of IGF-IR Inhibitors
27. Supplementary Materials and Methods from MM-141, an IGF-IR– and ErbB3-Directed Bispecific Antibody, Overcomes Network Adaptations That Limit Activity of IGF-IR Inhibitors
28. Supplementary Tables S5, S6, S7, S8 from Enhanced Targeting of the EGFR Network with MM-151, an Oligoclonal Anti-EGFR Antibody Therapeutic
29. Supplementary Figures 1-4, Table 1 from Antitumor Activity of a Novel Bispecific Antibody That Targets the ErbB2/ErbB3 Oncogenic Unit and Inhibits Heregulin-Induced Activation of ErbB3
30. Supplemental Figure 3 from Heregulin–ErbB3-Driven Tumor Growth Persists in PI3 Kinase Mutant Cancer Cells
31. Supplementary Figure Legends from MM-141, an IGF-IR– and ErbB3-Directed Bispecific Antibody, Overcomes Network Adaptations That Limit Activity of IGF-IR Inhibitors
32. Data from Heregulin–ErbB3-Driven Tumor Growth Persists in PI3 Kinase Mutant Cancer Cells
33. Data from MM-141, an IGF-IR– and ErbB3-Directed Bispecific Antibody, Overcomes Network Adaptations That Limit Activity of IGF-IR Inhibitors
34. Supplementary Table S1 from Enhanced Targeting of the EGFR Network with MM-151, an Oligoclonal Anti-EGFR Antibody Therapeutic
35. Supplemental table 1 from Heregulin–ErbB3-Driven Tumor Growth Persists in PI3 Kinase Mutant Cancer Cells
36. Supplemental Figure 1 from Heregulin–ErbB3-Driven Tumor Growth Persists in PI3 Kinase Mutant Cancer Cells
37. Supplementary Figures S1-S6 from Cyclophosphamide-Mediated Tumor Priming for Enhanced Delivery and Antitumor Activity of HER2-Targeted Liposomal Doxorubicin (MM-302)
38. Supplemental table 2 from Heregulin–ErbB3-Driven Tumor Growth Persists in PI3 Kinase Mutant Cancer Cells
39. Supplementary Figure Legend from Impact of Intrinsic Affinity on Functional Binding and Biological Activity of EGFR Antibodies
40. Supplementary Table 3 from Impact of Intrinsic Affinity on Functional Binding and Biological Activity of EGFR Antibodies
41. Supplementary Tables S2, S3, S4 from Enhanced Targeting of the EGFR Network with MM-151, an Oligoclonal Anti-EGFR Antibody Therapeutic
42. Supplemental Figure 2 from Heregulin–ErbB3-Driven Tumor Growth Persists in PI3 Kinase Mutant Cancer Cells
43. Supplementary Figure 1 from Impact of Intrinsic Affinity on Functional Binding and Biological Activity of EGFR Antibodies
44. Supplementary Figures 1 through 10 and Supplementary Tables 1 through 3 from MM-141, an IGF-IR– and ErbB3-Directed Bispecific Antibody, Overcomes Network Adaptations That Limit Activity of IGF-IR Inhibitors
45. Supplementary Tables S1-S3 from Cyclophosphamide-Mediated Tumor Priming for Enhanced Delivery and Antitumor Activity of HER2-Targeted Liposomal Doxorubicin (MM-302)
46. Supplementary Methods, Figures S1-S11, and Table Legends from Enhanced Targeting of the EGFR Network with MM-151, an Oligoclonal Anti-EGFR Antibody Therapeutic
47. Supplementary Materials and Methods from Cyclophosphamide-Mediated Tumor Priming for Enhanced Delivery and Antitumor Activity of HER2-Targeted Liposomal Doxorubicin (MM-302)
48. Supplemental figure legends from Heregulin–ErbB3-Driven Tumor Growth Persists in PI3 Kinase Mutant Cancer Cells
49. Supplementary Figure 2 from Impact of Intrinsic Affinity on Functional Binding and Biological Activity of EGFR Antibodies
50. Supplementary Table 2 from Impact of Intrinsic Affinity on Functional Binding and Biological Activity of EGFR Antibodies
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.